There has been an increase in CEA overexpression in 90% of gastrointestinal cancers, including CRC tumor recurrence is predicted by an increase in postoperative CA125 and CA199 levels, and this information is critical for the diagnosis of digestive system cancer.67, 68. The gene discussed is CEACAM5; the disease is colorectal carcinoma.